For the broader obesity pharmacology field, it opens a template for central drugs that operate where peripheral gut-hormone therapies cannot reach
Patients receive better clinical outcomes and fewer adverse effects from GLP-1based therapy treatments when compared to existing medications, including orlistat and phentermine/topiramate
that dose allows you to hew closer to 100mg or 200mg, depending on your size, any perceived effects, and conversations with your doctor
Research shows mixed results
They will also take into consideration whether the patient is on other drugs that might be obesogenic, meaning causing weight gain, or if they are using an FDA-approved GLP-1 drug versus a compounded medication, which can have variable quality and unknown efficacy Balancing weight loss with bone health Helpful strategies to prevent weight regain related to diet include building meals around lean protein and noticing where calories might be creeping in, such as snacks, sugary drinks and alcohol
*Correspondence: Samantha Messina, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
